About Panacea Medical Technologies Private Limited
Data last updated: 02 July 2026
Panacea Medical Technologies Private Limited is a private limited company based in Malur, Karnataka, India. It specialises in oncology clinics and cancer treatment, a part of the broader healthcare sector. Incorporated on 26 March 1999, the company has been in operation for over 27 years.
Registered with ROC Bangalore under CIN U33112AP1999PTC031410.
Capital: an authorised share capital of ₹41 Cr and a paid-up capital of ₹39.39 Cr. It is led by directors including Satyalakshmi Goteti and Venkata Subrahmanyam Goteti.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.35 4Th Phase Kiadb Industrial Area, Malur, Karnataka, India – 563130.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.58 Cr, a growth of 1% compared to the previous year.
The company has a workforce of approximately 373 employees as per the latest available data.
The company is associated with 1 brand - Panacea Medical. As per MCA filings, the company has open charges of ₹94.28 Cr and satisfied charges of ₹75.96 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website panaceamedical.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressPlot No.35 4Th Phase Kiadb Industrial Area, Malur, Karnataka, India – 563130
-
IndustryHealthcare, Oncology Clinics & Cancer Treatment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Panacea Medical Technologies Private Limited
Panacea Medical Technologies Private Limited has one previous CIN (Corporate Identification Number): U33112AP1999PTC031410. The current CIN is U33112KA1999PTC079963, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33112KA1999PTC079963 | Current |
| U33112AP1999PTC031410 | Previous |
Associated Brands with Panacea Medical Technologies Private Limited
Panacea Medical Technologies Private Limited operates one associated brand: Panacea Medical. These brands represent Panacea Medical Technologies Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Radiotherapy and mammography devices are developed for medical use. | panaceamedical.in |
Competitors & Alternatives of Panacea Medical Technologies Private Limited
Brands and companies operating in the same space as Panacea Medical Technologies Private Limited include CairnSurgical, Niramai, UE LifeSciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
CairnSurgical
|
Developer of 3D printed surgical guides for breast cancer treatment | Lebanon, United States, United States | 2015 |
Niramai
|
Early breast cancer is detected using AI-based non-invasive thermal imaging. | Bengaluru, India, India | 2016 |
UE LifeSciences
|
Non-invasive devices for breast and cervical cancer screening are provided. | Philadelphia, United States, United States | 2009 |
Micrima
|
Breast cancer is detected via non-invasive radio wave technology. | Bristol, United Kingdom, United Kingdom | 2005 |
Vayyar
|
Developer of 4D imaging sensors for cancer detection and other devices | Yehud, Israel, Israel | 2011 |
CMR Naviscan
|
High-resolution PET scanners for breast imaging are developed and manufactured. | San Diego, United States, United States | 1995 |
Dune Medical
|
Intraoperative cancer detection devices are developed for real-time tissue assessment. | Alpharetta, United States, United States | 2002 |
Olive Healthcare
|
Devices and software for wellness and medical uses are provided. | Seoul, South Korea, South Korea | 2016 |
Business Activity of Panacea Medical Technologies Private Limited
Panacea Medical Technologies Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | ********* |
Board of Directors of Panacea Medical Technologies Private Limited
Panacea Medical Technologies Private Limited is currently managed by 8 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyalakshmi Goteti | Director | 22 Sep 2005 | 20 Years 9 Months | Current |
| Venkata Subrahmanyam Goteti | Managing Director | 26 Mar 1999 | 27 Years 3 Months | Current |
| Ramann Yerramilli | Director | 25 Sep 2003 | 22 Years 9 Months | Current |
| Nagavalli Goteti | Director | 20 Apr 2008 | 18 Years 2 Months | Current |
|
Sunil Kumar Khurana
Also directs:
Bpl Medical Technologies Private Limited
|
Nominee Director | 02 May 2025 | 1 Years 2 Months | Current |
|
Shravan Subramanyam
Also directs:
Pangolin Ventures Llp, Page Industries Limited, Bpl Medical Technologies Private Limited and 1 more
|
Nominee Director | 22 Feb 2025 | 1 Years 4 Months | Current |
Financials of Panacea Medical Technologies Private Limited FY 2025 filings available
Panacea Medical Technologies Private Limited reported revenue of ₹99.58 Cr (up 1% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Panacea Medical Technologies Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2026 | State Bank of India | ₹1.07 Cr | Open |
| 27 Mar 2026 | Others | ₹13.95 Lakh | Open |
| 27 Mar 2026 | Others | ₹13.95 Lakh | Open |
| 27 Mar 2026 | Others | ₹6.9 Lakh | Open |
| 27 Mar 2026 | Others | ₹6.9 Lakh | Open |
Total charge records: 38 View all charges
Employees and EPFO Compliance at Panacea Medical Technologies Private Limited
View historical data on people associated with Panacea Medical Technologies Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Panacea Medical Technologies Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Panacea Medical Technologies Private Limited
GSTIN & GST Filing Data of Panacea Medical Technologies Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Panacea Medical Technologies Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Panacea Medical Technologies Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Panacea Medical Technologies Private Limited
MSME Payment Delays by Panacea Medical Technologies Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Panacea Medical Technologies Private Limited
Subsidiaries & Group Companies of Panacea Medical Technologies Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Panacea Medical Technologies Private Limited with ownership details.
MCA Filings & Documents of Panacea Medical Technologies Private Limited
MCA Filings & Documents of Panacea Medical Technologies Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Panacea Medical Technologies Private Limited
Frequently Asked Questions about Panacea Medical Technologies Private Limited
Panacea Medical Technologies Private Limited is an active private limited company in the healthcare sector based in Malur, Karnataka, India. It was incorporated on 26 March 1999 (27+ years old) and is registered under CIN U33112KA1999PTC079963. The company has 373 employees.
Panacea Medical Technologies Private Limited reported revenue of ₹99.58 Cr for FY 2025 (up 1.00% YoY).
The current directors of Panacea Medical Technologies Private Limited are:
The primary industry of Panacea Medical Technologies Private Limited is healthcare. The company specifically operates in oncology clinics and cancer treatment. The company is currently active in this sector.
Panacea Medical Technologies Private Limited can be reached at the registered office: Plot No.35 4Th Phase Kiadb Industrial Area, Malur, Karnataka, India – 563130, or through the website panaceamedical.in.
The authorised capital is ₹41 Cr, and the paid-up capital is ₹39.39 Cr.